Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
BioMarin Pharmaceutical Inc. (BMRN) had Operating Cash Flow per Share of $2.00 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$989.71M |
|
$44.76M |
|
$202.79M |
|
$786.91M |
|
$878.79M |
|
$110.92M |
|
$-49.54M |
|
$61.38M |
|
$61.38M |
|
$44.76M |
|
$44.76M |
|
$44.76M |
|
$44.76M |
|
$110.92M |
|
$209.01M |
|
193.42M |
|
194.47M |
|
$0.23 |
|
$0.23 |
|
| Balance Sheet Financials | |
$3.97B |
|
$989.99M |
|
$7.75B |
|
$11.72B |
|
$1.66B |
|
$3.53B |
|
$3.74B |
|
$5.40B |
|
$6.32B |
|
$786.58M |
|
$6.32B |
|
193.54M |
|
| Cash Flow Statement Financials | |
$388.76M |
|
$-4.38B |
|
$3.55B |
|
$1.31B |
|
$874.00M |
|
$-437.67M |
|
$119.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.39 |
|
-- |
|
-- |
|
0.36 |
|
0.66 |
|
79.51% |
|
11.21% |
|
11.21% |
|
-- |
|
6.20% |
|
4.52% |
|
$339.02M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.11 |
|
0.93 |
|
96.49 |
|
0.71% |
|
5.69% |
|
0.38% |
|
0.45% |
|
$32.66 |
|
$1.74 |
|
|
Operating Cash Flow per Share |
$2.00 |